Tags: FDA

5/5/2017

Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?

4/4/2017

FDA could do a better job sharing numbers on costly new eczema drug

3/14/2017

FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good

2 1/31/2017

How big is symptom improvement with new constipation drug? Readers might have to strain to find out

11/28/2016

FDA release on Intrarosa approval omits important conflict of interest

9/30/2016

FDA release offers inadequate presentation of auto-inflammatory drug approval

7/6/2016

FDA release on hepatitis C drug informs on harms, benefits but is light on evidence

1 5/24/2016

FDA PR release on bladder cancer drug skirts lack of long-term survival data

1 5/10/2016

FDA release on drug for treating Parkinson’s psychosis lacks some key details

12/15/2015

FDA skims over benefits and costs of cooling cap it approved for reducing hair loss during chemo